Optiver Holding
TARS icon

Optiver Holding’s Tarsus Pharmaceuticals TARS Stock Holding History

Optiver Holding’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Buy
242
+41
+20% +$2.62K ﹤0.01% 1624
2026
Q1 		$14.1K Buy
201
+12
+6% +$838 ﹤0.01% 1160
2025
Q4 		$15.5K Sell
189
-91
-33% -$6.79K ﹤0.01% 1074
2025
Q3 		$16.6K Buy
280
+8
+3% +$394 ﹤0.01% 1032
2025
Q2 		$11K Buy
272
+88
+48% +$3.96K ﹤0.01% 974
2025
Q1 		$9.45K Buy
+184
New +$9.1K ﹤0.01% 904

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Optiver Holding's TARS Position: Q2 2026 in Review

Optiver Holding increased its Tarsus Pharmaceuticals (TARS) stake by 20% in Q2 2026, buying an estimated $2.62K and bringing the position to 242 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Optiver Holding first reported a position in TARS in Q1 2025 and has held it in 6 quarters since. The position peaked at $16.6K in Q3 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Optiver Holding held 242 shares of Tarsus Pharmaceuticals worth $15.2K as of Q2 2026.
  • Optiver Holding bought 41 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $2.62K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1624 holding.
  • Optiver Holding first reported a position in Tarsus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Optiver Holding's Tarsus Pharmaceuticals position peaked at $16.6K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.